» Articles » PMID: 24399100

Utilization Patterns of Conventional and Complementary/alternative Treatments in Children with Autism Spectrum Disorders and Developmental Disabilities in a Population-based Study

Overview
Date 2014 Jan 9
PMID 24399100
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the utilization of conventional treatments and utilization of complementary and alternative medicine in preschoolers with autism spectrum disorders (ASD) and other developmental disabilities (DD).

Methods: Participants were 578 children who were part of an ongoing population-based, case-control study of 2- to 5-year olds with ASD, DD, and the general population. Parents completed an interview on past and current services.

Results: Four hundred fifty-three children with ASD and 125 DD children were included. ASD families received more hours of conventional services compared with DD families (17.8 vs 11; p < .001). The use of psychotropic medications was low in both groups (approximately 3%). Overall, complementary and alternative medicine (CAM) use was not significantly different in ASD (39%) versus DD (30%). Hispanic families in both groups used CAM less often than non-Hispanic families. Variables such as level of function, immunization status, and the presence of an identified neurogenetic disorder were not predictive of CAM use. A higher level of parental education was associated with an increased CAM use in ASD and DD. Families who used >20 hours per week of conventional services were more likely to use CAM, including potentially unsafe or disproven CAM. Underimmunized children were marginally more likely to use CAM but not more likely to have received potentially unsafe or disproven CAM.

Conclusion: Use of CAM is common in families of young children with neurodevelopmental disorders, and it is predicted by higher parental education and non-Hispanic ethnicity but not developmental characteristics. Further research should address how health care providers can support families in making decisions about CAM use.

Citing Articles

The use of psychotropic medications in autistic individuals (21 years and younger) in Western Australia: A preliminary investigation.

Bulonza R, Watkins K, Parsons R, Sunderland B, Whitehouse A, Caccetta R Autism. 2024; 28(8):2002-2013.

PMID: 38385262 PMC: 11301957. DOI: 10.1177/13623613231226099.


Sibling Support and Perceived Daily Hassles in Latino and Non-Latino Families of Children with DD.

Sanner C, Benjamin L, Eskander C, McGregor H, Preston A, Lee McIntyre L Fam J Alex Va. 2023; 31(2):330-340.

PMID: 37817893 PMC: 10564384. DOI: 10.1177/10664807221151174.


Assessing the Effectiveness of Professional Development Training on Autism and Culturally Responsive Practice for Educators and Practitioners in Ethiopia.

Zeleke W, Hughes T, Kanyongo G Front Psychiatry. 2021; 11:583674.

PMID: 33708144 PMC: 7940830. DOI: 10.3389/fpsyt.2020.583674.


Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis.

Shuai B, Jin H, Lin Y, Duan R, Zhao N, Li Z Medicine (Baltimore). 2020; 99(45):e23128.

PMID: 33157993 PMC: 7647561. DOI: 10.1097/MD.0000000000023128.


Complementary and Alternative Medicine Use in Children with a Developmental Disability and Co-occurring Medical Conditions.

Zisman C, Patti M, Kalb L, Stapp E, Van Eck K, Volk H Complement Ther Med. 2020; 53:102527.

PMID: 33066848 PMC: 9052702. DOI: 10.1016/j.ctim.2020.102527.


References
1.
Rosenberg R, Law J, Anderson C, Samango-Sprouse C, Law P . Survey of vaccine beliefs and practices among families affected by autism spectrum disorders. Clin Pediatr (Phila). 2012; 52(9):871-4. DOI: 10.1177/0009922812438435. View

2.
Huffman L, Sutcliffe T, Tanner I, Feldman H . Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments. J Dev Behav Pediatr. 2010; 32(1):56-68. DOI: 10.1097/DBP.0b013e3182040acf. View

3.
Rosenberg R, Mandell D, Farmer J, Law J, Marvin A, Law P . Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. J Autism Dev Disord. 2009; 40(3):342-51. DOI: 10.1007/s10803-009-0878-1. View

4.
Buie T, Campbell D, Fuchs 3rd G, Furuta G, Levy J, Vandewater J . Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010; 125 Suppl 1:S1-18. DOI: 10.1542/peds.2009-1878C. View

5.
Levy S, Mandell D, Merhar S, Ittenbach R, Pinto-Martin J . Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr. 2003; 24(6):418-23. DOI: 10.1097/00004703-200312000-00003. View